Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.
Vici P, Viola G, Botti C, Rossi S, Vitucci C, Corsetti S, Di Lauro L, Sergi D, Foggi P, Perri P, Tirelli C, Mottolese M, Fattoruso SI, Lopez M.
Vici P, et al. Among authors: sergi d.
Clin Ter. 2008 Nov-Dec;159(6):449-52.
Clin Ter. 2008.
PMID: 19169607
Review.